Abstract

Plant originated drugs/formulations are extensively prescribed by the physicians as a complementary therapy for treating various human ailments including cancer. In this study Prosopis juliflora leaves methanol extract was prepared and exposed to human breast cancer cell lines i.e. MDA-MB-231 and MCF-7 and human keratinocytes HaCaT as a representative of normal cells. Initially, a series of in vitro experiments like cell proliferation, migration, colony formation, cell cycle arrest and inhibition of angiogenesis. After confirmation of the efficient and selective activity against triple negative breast cancer cell line, we further evaluated the possible mechanism of inducing cell death and experiments like detection of reactive oxygen species, caspases and poly (ADP-ribose) polymerase cleavage study and Annexin V assay were performed. We also evaluated in vivo anti tumorigenic activity of the P. juliflora leaves by using 4T1 cells (a triple negative mouse origin breast cancer cell line) and BALB/c xenograft mouse model. In vitro experiments revealed that methanol extract of Prosopis juliflora leaves possess impressive anti-breast cancer activity more specifically against triple negative breast cancer cells, while the in vivo studies demonstrated that P. juliflora leaves extract significantly suppressed the 4T1 induced tumor growth. Present investigations clearly focus the significance of P. juliflora as an important resource for finding novel leads against triple negative breast cancer. The results may also act as a ready reference towards developing P. juliflora based formulation as an alternative and complementary medicine for the management of breast cancer.

Highlights

  • The media center of WHO in Feb 2017 [1] states that breast cancer mortality ranks fifth amongst the cancer related deaths in world, the breast cancer related mortality is increasing both in the developed and the developing countries

  • In vitro experiments revealed that methanol extract of Prosopis juliflora leaves possess impressive anti-breast cancer activity against triple negative breast cancer cells, while the in vivo studies demonstrated that P. juliflora leaves extract significantly suppressed the 4T1 induced tumor growth

  • The results may act as a ready reference towards developing P. juliflora based formulation as an alternative and complementary medicine for the management of breast cancer

Read more

Summary

Introduction

The media center of WHO in Feb 2017 [1] states that breast cancer mortality ranks fifth amongst the cancer related deaths in world, the breast cancer related mortality is increasing both in the developed and the developing countries. It has been estimated that over 266,120 new cases of invasive breast cancer will be diagnosed among women and over 2,550 cases will be diagnosed in men in 2018. There forecast alarms that over 63,960 cases of in situ breast carcinoma will be diagnosed in women. It is speculated that approximately 40,920 women and 480 men are expected to succumb to death from breast cancer in 2018 [2]. Based on the routinely evaluated biological markers molecular subtypes of breast cancers have been classified as presence or absence of hormone (estrogen or progesterone) receptors (HR+/HR-) and presence or absence of excess levels of human epidermal growth factor receptor 2 (HER2+/HER2-). Four main molecular subtypes such as Luminal A (HR+/HER2-) (accounting 71%), triple negative breast cancer: TNBC (HR-/HER2-) (accounting 12%), Luminal B (HR+/HER2+) (accenting 12%) and HER2-enriched (HR-/HER2+) (accounting 5%) have been described. In India TNBC cases prevalence is higher than the other countries in the world [5]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.